Hematological Malignancy: Clinical Trials

2 trials for Hematological Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Unknown 2
Phase 21Unknown 1

Follow Hematological Malignancy: new trials by email Literature Review of Hematological Malignancy trials Research Report on Hematological Malignancy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors
Shengxuening Tablet, Ferrous succinate - Hematological Malignancy, Cancer-Related Anemia
Phase 3UnknownZhongnan Hospital1682023-02-072023-08-25
Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours
CAR-T cell therapy - Hematological Malignancy
Phase 2 / Phase 3UnknownShanxi Bethune Hospital302020-06-152024-02-02

Narrower conditions

Hematologic Neoplasms (2)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)

Interventions

Immunotherapy, Adoptive (1)  ·  ferrous succinate (1)  ·  shengxuening (1)

Sponsors

Shanxi Bethune Hospital (1)  ·  Zhongnan Hospital (1)

Countries

China (2)

Top investigators

Xiaomin Zhang (1)